# TiumBio Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tiumbio-co

- Industry: Pharmaceuticals
- Headquarters: Seongnam, South Korea
- Website: www.tiumbio.com
- Total disclosed funding: $32M
- Latest round: Series B (May 22, 2018)
- Investors on record: 9

## About

Founded in 2016 and based in Seongnam, South Korea, TiumBio Co., Ltd. is a biopharmaceutical company that engages in the research and development of therapeutic drugs for rare diseases.

## Funding rounds

- Series B, May 22, 2018, $22M — Korea Development Bank, WOORI Venture Partners, Korea Investment Partners, DSC Investment, IMM Investment, Premier Partners, Kiwoom Securities, Hyundai Investment Partners, STIC Ventures
- Series A, May 11, 2017, $11M — WOORI Venture Partners, Korea Investment Partners

## Investors

- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series A, Series B
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A, Series B
- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series B
- DSC Investment (https://capitalatlas.ai/funds/dsc-investment) — Series B
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series B
- Premier Partners (https://capitalatlas.ai/funds/premier-partners) — Series B
- Kiwoom Securities — Series B
- Hyundai Investment Partners (https://capitalatlas.ai/funds/hyundai-investment-partners) — Series B
- STIC Ventures (https://capitalatlas.ai/funds/stic-ventures) — Series B